Phase II study of S-1 in patients with advanced biliary tract cancer

Por Ueno, H, Okusaka, T, Ikeda, M, Takezako, Y, Morizane, C
Publicado em 2004

P-120 Gemcitabine + nab-paclitaxel as first-line chemotherapy for Japanese patients with advanced pancreatic cancer in real-world clinical practice: a retrospective study

Por Yamaguchi, T., Ueno, H., Sasaki, M., Sakamoto, Y., Kondo, S., Morizane, C., Okusaka, T.
Publicado no Ann Oncol (2016)

P-103 Prognostic factors for survival in patients with advanced intrahepatic cholangiocarcinoma treated with gemcitabine plus cisplatin as first line treatment

Por Ishimoto, U., Sasaki, M., Kondo, S., Sakamoto, Y., Morizane, C., Ueno, H., Okusaka, T.
Publicado no Ann Oncol (2016)

Clinical impact of pentraxin family expression on prognosis of pancreatic carcinoma

Por Kondo, S, Ueno, H, Hosoi, H, Hashimoto, J, Morizane, C, Koizumi, F, Tamura, K, Okusaka, T
Publicado em 2013

P-119 Chemoradiotherapy versus chemotherapy alone for unresectable locally advanced pancreatic cancer: a retrospective cohort study

Por Maruki, Y., Ueno, H., Sasaki, M., Sakamoto, Y., Kondo, S., Morizane, C., Ito, Y., Okusaka, T.
Publicado no Ann Oncol (2016)

Phase II study of radiotherapy combined with gemcitabine for locally advanced pancreatic cancer

Por Okusaka, T, Ito, Y, Ueno, H, Ikeda, M, Takezako, Y, Morizane, C, Kagami, Y, Ikeda, H
Publicado em 2004

P-122 Phase I study of S-1, irinotecan plus oxaliplatin combination therapy (S-IROX) for Unresectable pancreatic ductal adenocarcinoma

Por Sasaki, M., Ueno, H., Shiba, S., Hosoi, H., Akihiro, O., Sakamoto, Y., Kondo, S., Morizane, C., Okusaka, T.
Publicado no Ann Oncol (2016)

A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer

Por Ikeda, M, Okusaka, T, Ito, Y, Ueno, H, Morizane, C, Furuse, J, Ishii, H, Kawashima, M, Kagami, Y, Ikeda, H
Publicado em 2007

Homozygous CDA*3 is a major cause of life-threatening toxicities in gemcitabine-treated Japanese cancer patients

Por Ueno, H, Kaniwa, N, Okusaka, T, Ikeda, M, Morizane, C, Kondo, S, Sugiyama, E, Kim, S R, Hasegawa, R, Saito, Y, Yoshida, T, Saijo, N, Sawada, J
Publicado em 2009

A phase I and pharmacokinetic study of NK105, a paclitaxel-incorporating micellar nanoparticle formulation

Por Hamaguchi, T, Kato, K, Yasui, H, Morizane, C, Ikeda, M, Ueno, H, Muro, K, Yamada, Y, Okusaka, T, Shirao, K, Shimada, Y, Nakahama, H, Matsumura, Y
Publicado em 2007

ACTN4 copy number increase as a predictive biomarker for chemoradiotherapy of locally advanced pancreatic cancer

Por Watanabe, T, Ueno, H, Watabe, Y, Hiraoka, N, Morizane, C, Itami, J, Okusaka, T, Miura, N, Kakizaki, T, Kakuya, T, Kamita, M, Tsuchida, A, Nagakawa, Y, Wilber, H, Yamada, T, Honda, K
Publicado no Br J Cancer (2015)